Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: KBV Research | PRODUCT CODE: 1373648

Cover Image

PUBLISHER: KBV Research | PRODUCT CODE: 1373648

LAMEA Autism Spectrum Disorder Treatment Market Size, Share & Industry Trends Analysis Report By Type, By Application, By Distribution Channel (Retail Pharmacy, Hospital Pharmacy and Online Pharmacy), By Country and Growth Forecast, 2023 - 2030

PUBLISHED:
PAGES: 132 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 1500
PDF (Site License)
USD 1800
PDF (Enterprisewide License)
USD 2520

Add to Cart

The Latin America, Middle East and Africa Autism Spectrum Disorder Treatment Market would witness market growth of 11.9% CAGR during the forecast period (2023-2030).

ASD-related symptoms can appear in children as young as 12 months old and can evolve over time. Due to the clutter's vast range in the type and severity of symptoms, the term "spectrum" is frequently used to refer to autistic clutter. Additionally, the various kinds of ASD are caused by the fusions of a few inherited variants. However, non-inherited features and both frequent and rare inherited variations in genetics play a role in the emergence of ASD. Patients with ASD, according to the DSM-5, struggle with social contact, communication, activities, and nonverbal intelligence. They also exhibit repetitive behavioural patterns.

Patients might benefit from regular behavioral therapy, especially concerning cognitive skills. Positive treatment for these patients has been made possible by improved therapy techniques and public awareness. Additionally, drugs are being developed to treat a variety of emotional and behavioral issues, including anxiety, irritability, aggression, hyperactivity, and depression. It is projected that the study and creation of new medications to treat people with ASD will favorably influence market expansion.

ASD prevalence rates in Latin America vary by country and region. Accurate prevalence data can be challenging to obtain due to differences in diagnostic criteria, access to healthcare, and awareness levels. Some countries have reported prevalence rates ranging from 1 in 500 to 1 in 150 individuals. While progress has been made, challenges remain, including increased access to services, training for professionals, and public awareness campaigns that will aid in reducing stigma and promoting inclusion. Collaboration between government agencies, advocacy organizations, and the international autism community has played a crucial role in advancing autism initiatives in the region. Therefore, owing to all these elements, the market is expected to expand significantly in the coming years.

The Brazil market dominated the LAMEA Autism Spectrum Disorder Treatment Market, by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $46.3 Million by 2030. The Argentina market is anticipated to grow at a CAGR of 12.5% during (2023 - 2030). Additionally, The UAE market would exhibit a CAGR of 11.6% during (2023 - 2030).

Based on Type, the market is segmented into Stimulants, Antipsychotic Drugs, Selective Serotonin Reuptake Inhibitors, Sleep Medications, and Others. Based on Application, the market is segmented into Autistic Disorder, Asperger Syndrome, Pervasive, Developmental Disorder, and Others. Based on Distribution Channel, the market is segmented into Retail Pharmacy, Hospital Pharmacy and Online Pharmacy. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include F. Hoffmann-La Roche Ltd., Bristol Myers Squibb Company, Merck & Co., Inc., Novartis AG, Eli Lilly And Company, Pfizer Inc., Johnson & Johnson, Otsuka Pharmaceutical Co., Ltd., Yamo Pharmaceuticals, and Curemark LLC

Scope of the Study

Market Segments covered in the Report:

By Type

  • Stimulants
  • Antipsychotic Drugs
  • Selective Serotonin Reuptake Inhibitors
  • Sleep Medications
  • Others

By Application

  • Autistic Disorder
  • Asperger Syndrome
  • Pervasive Developmental Disorder
  • Others

By Distribution Channel

  • Retail Pharmacy
  • Hospital Pharmacy
  • Online Pharmacy

By Country

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled

  • F. Hoffmann-La Roche Ltd.
  • Bristol Myers Squibb Company
  • Merck & Co., Inc.
  • Novartis AG
  • Eli Lilly And Company
  • Pfizer Inc.
  • Johnson & Johnson
  • Otsuka Pharmaceutical Co., Ltd.
  • Yamo Pharmaceuticals
  • Curemark LLC

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 LAMEA Autism Spectrum Disorder Treatment Market, by Type
    • 1.4.2 LAMEA Autism Spectrum Disorder Treatment Market, by Application
    • 1.4.3 LAMEA Autism Spectrum Disorder Treatment Market, by Distribution Channel
    • 1.4.4 LAMEA Autism Spectrum Disorder Treatment Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market at a Glance

  • 2.1 Key Highlights

Chapter 3. Market Overview

  • 3.1 Introduction
    • 3.1.1 Overview
      • 3.1.1.1 Market Composition and Scenario
  • 3.2 Key Factors Impacting the Market
    • 3.2.1 Market Drivers
    • 3.2.2 Market Restraints
  • 3.3 Porter Five Forces Analysis

Chapter 4. LAMEA Autism Spectrum Disorder Treatment Market, by Type

  • 4.1 LAMEA Stimulants Market, by Country
  • 4.2 LAMEA Antipsychotic Drugs Market, by Country
  • 4.3 LAMEA Selective Serotonin Reuptake Inhibitors Market, by Country
  • 4.4 LAMEA Sleep Medications Market, by Country
  • 4.5 LAMEA Others Market, by Country

Chapter 5. LAMEA Autism Spectrum Disorder Treatment Market, by Application

  • 5.1 LAMEA Autistic Disorder Market, by Country
  • 5.2 LAMEA Asperger Syndrome Market, by Country
  • 5.3 LAMEA Pervasive Developmental Disorder Market, by Country
  • 5.4 LAMEA Others Market, by Country

Chapter 6. LAMEA Autism Spectrum Disorder Treatment Market, by Distribution Channel

  • 6.1 LAMEA Retail Pharmacy Market, by Country
  • 6.2 LAMEA Hospital Pharmacy Market, by Country
  • 6.3 LAMEA Online Pharmacy Market, by Country

Chapter 7. LAMEA Autism Spectrum Disorder Treatment Market, by Country

  • 7.1 Brazil Autism Spectrum Disorder Treatment Market
    • 7.1.1 Brazil Autism Spectrum Disorder Treatment Market, by Type
    • 7.1.2 Brazil Autism Spectrum Disorder Treatment Market, by Application
    • 7.1.3 Brazil Autism Spectrum Disorder Treatment Market, by Distribution Channel
  • 7.2 Argentina Autism Spectrum Disorder Treatment Market
    • 7.2.1 Argentina Autism Spectrum Disorder Treatment Market, by Type
    • 7.2.2 Argentina Autism Spectrum Disorder Treatment Market, by Application
    • 7.2.3 Argentina Autism Spectrum Disorder Treatment Market, by Distribution Channel
  • 7.3 UAE Autism Spectrum Disorder Treatment Market
    • 7.3.1 UAE Autism Spectrum Disorder Treatment Market, by Type
    • 7.3.2 UAE Autism Spectrum Disorder Treatment Market, by Application
    • 7.3.3 UAE Autism Spectrum Disorder Treatment Market, by Distribution Channel
  • 7.4 Saudi Arabia Autism Spectrum Disorder Treatment Market
    • 7.4.1 Saudi Arabia Autism Spectrum Disorder Treatment Market, by Type
    • 7.4.2 Saudi Arabia Autism Spectrum Disorder Treatment Market, by Application
    • 7.4.3 Saudi Arabia Autism Spectrum Disorder Treatment Market, by Distribution Channel
  • 7.5 South Africa Autism Spectrum Disorder Treatment Market
    • 7.5.1 South Africa Autism Spectrum Disorder Treatment Market, by Type
    • 7.5.2 South Africa Autism Spectrum Disorder Treatment Market, by Application
    • 7.5.3 South Africa Autism Spectrum Disorder Treatment Market, by Distribution Channel
  • 7.6 Nigeria Autism Spectrum Disorder Treatment Market
    • 7.6.1 Nigeria Autism Spectrum Disorder Treatment Market, by Type
    • 7.6.2 Nigeria Autism Spectrum Disorder Treatment Market, by Application
    • 7.6.3 Nigeria Autism Spectrum Disorder Treatment Market, by Distribution Channel
  • 7.7 Rest of LAMEA Autism Spectrum Disorder Treatment Market
    • 7.7.1 Rest of LAMEA Autism Spectrum Disorder Treatment Market, by Type
    • 7.7.2 Rest of LAMEA Autism Spectrum Disorder Treatment Market, by Application
    • 7.7.3 Rest of LAMEA Autism Spectrum Disorder Treatment Market, by Distribution Channel

Chapter 8. Company Profiles

  • 8.1 F. Hoffmann-La Roche Ltd.
    • 8.1.1 Company Overview
    • 8.1.2 Financial Analysis
    • 8.1.3 Segmental and Regional Analysis
    • 8.1.4 Research & Development Expense
    • 8.1.5 SWOT Analysis
  • 8.2 Bristol Myers Squibb Company
    • 8.2.1 Company Overview
    • 8.2.2 Financial Analysis
    • 8.2.3 Regional Analysis
    • 8.2.4 Research & Development Expenses
    • 8.2.5 SWOT Analysis
  • 8.3 Merck & Co., Inc.
    • 8.3.1 Company Overview
    • 8.3.2 Financial Analysis
    • 8.3.3 Segmental and Regional Analysis
    • 8.3.4 Research & Development Expenses
    • 8.3.5 SWOT Analysis
  • 8.4 Novartis AG
    • 8.4.1 Company Overview
    • 8.4.2 Financial Analysis
    • 8.4.3 Segmental and Regional Analysis
    • 8.4.4 Research & Development Expense
    • 8.4.5 SWOT Analysis
  • 8.5 Eli Lilly And Company
    • 8.5.1 Company Overview
    • 8.5.2 Financial Analysis
    • 8.5.3 Regional Analysis
    • 8.5.4 Research & Development Expenses
    • 8.5.5 SWOT Analysis
  • 8.6 Pfizer, Inc.
    • 8.6.1 Company Overview
    • 8.6.2 Financial Analysis
    • 8.6.3 Regional & Segmental Analysis
    • 8.6.4 Research & Development Expense
    • 8.6.5 SWOT Analysis
  • 8.7 Johnson & Johnson
    • 8.7.1 Company Overview
    • 8.7.2 Financial Analysis
    • 8.7.3 Segmental & Regional Analysis
    • 8.7.4 Research & Development Expenses
    • 8.7.5 SWOT Analysis
  • 8.8 Otsuka Pharmaceutical Co., Ltd.
    • 8.8.1 Company Overview
    • 8.8.2 SWOT Analysis
  • 8.9 Yamo Pharmaceuticals
    • 8.9.1 Company Overview
    • 8.9.2 SWOT Analysis
  • 8.10. Curemark, LLC
    • 8.10.1 Company Overview
    • 8.10.2 SWOT Analysis

LIST OF TABLES

  • TABLE 1 LAMEA Autism Spectrum Disorder Treatment Market, 2019 - 2022, USD Million
  • TABLE 2 LAMEA Autism Spectrum Disorder Treatment Market, 2023 - 2030, USD Million
  • TABLE 3 LAMEA Autism Spectrum Disorder Treatment Market, by Type, 2019 - 2022, USD Million
  • TABLE 4 LAMEA Autism Spectrum Disorder Treatment Market, by Type, 2023 - 2030, USD Million
  • TABLE 5 LAMEA Stimulants Market, by Country, 2019 - 2022, USD Million
  • TABLE 6 LAMEA Stimulants Market, by Country, 2023 - 2030, USD Million
  • TABLE 7 LAMEA Antipsychotic Drugs Market, by Country, 2019 - 2022, USD Million
  • TABLE 8 LAMEA Antipsychotic Drugs Market, by Country, 2023 - 2030, USD Million
  • TABLE 9 LAMEA Selective Serotonin Reuptake Inhibitors Market, by Country, 2019 - 2022, USD Million
  • TABLE 10 LAMEA Selective Serotonin Reuptake Inhibitors Market, by Country, 2023 - 2030, USD Million
  • TABLE 11 LAMEA Sleep Medications Market, by Country, 2019 - 2022, USD Million
  • TABLE 12 LAMEA Sleep Medications Market, by Country, 2023 - 2030, USD Million
  • TABLE 13 LAMEA Others Market, by Country, 2019 - 2022, USD Million
  • TABLE 14 LAMEA Others Market, by Country, 2023 - 2030, USD Million
  • TABLE 15 LAMEA Autism Spectrum Disorder Treatment Market, by Application, 2019 - 2022, USD Million
  • TABLE 16 LAMEA Autism Spectrum Disorder Treatment Market, by Application, 2023 - 2030, USD Million
  • TABLE 17 LAMEA Autistic Disorder Market, by Country, 2019 - 2022, USD Million
  • TABLE 18 LAMEA Autistic Disorder Market, by Country, 2023 - 2030, USD Million
  • TABLE 19 LAMEA Asperger Syndrome Market, by Country, 2019 - 2022, USD Million
  • TABLE 20 LAMEA Asperger Syndrome Market, by Country, 2023 - 2030, USD Million
  • TABLE 21 LAMEA Pervasive Developmental Disorder Market, by Country, 2019 - 2022, USD Million
  • TABLE 22 LAMEA Pervasive Developmental Disorder Market, by Country, 2023 - 2030, USD Million
  • TABLE 23 LAMEA Others Market, by Country, 2019 - 2022, USD Million
  • TABLE 24 LAMEA Others Market, by Country, 2023 - 2030, USD Million
  • TABLE 25 LAMEA Autism Spectrum Disorder Treatment Market, by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 26 LAMEA Autism Spectrum Disorder Treatment Market, by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 27 LAMEA Retail Pharmacy Market, by Country, 2019 - 2022, USD Million
  • TABLE 28 LAMEA Retail Pharmacy Market, by Country, 2023 - 2030, USD Million
  • TABLE 29 LAMEA Hospital Pharmacy Market, by Country, 2019 - 2022, USD Million
  • TABLE 30 LAMEA Hospital Pharmacy Market, by Country, 2023 - 2030, USD Million
  • TABLE 31 LAMEA Online Pharmacy Market, by Country, 2019 - 2022, USD Million
  • TABLE 32 LAMEA Online Pharmacy Market, by Country, 2023 - 2030, USD Million
  • TABLE 33 LAMEA Autism Spectrum Disorder Treatment Market, by Country, 2019 - 2022, USD Million
  • TABLE 34 LAMEA Autism Spectrum Disorder Treatment Market, by Country, 2023 - 2030, USD Million
  • TABLE 35 Brazil Autism Spectrum Disorder Treatment Market, 2019 - 2022, USD Million
  • TABLE 36 Brazil Autism Spectrum Disorder Treatment Market, 2023 - 2030, USD Million
  • TABLE 37 Brazil Autism Spectrum Disorder Treatment Market, by Type, 2019 - 2022, USD Million
  • TABLE 38 Brazil Autism Spectrum Disorder Treatment Market, by Type, 2023 - 2030, USD Million
  • TABLE 39 Brazil Autism Spectrum Disorder Treatment Market, by Application, 2019 - 2022, USD Million
  • TABLE 40 Brazil Autism Spectrum Disorder Treatment Market, by Application, 2023 - 2030, USD Million
  • TABLE 41 Brazil Autism Spectrum Disorder Treatment Market, by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 42 Brazil Autism Spectrum Disorder Treatment Market, by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 43 Argentina Autism Spectrum Disorder Treatment Market, 2019 - 2022, USD Million
  • TABLE 44 Argentina Autism Spectrum Disorder Treatment Market, 2023 - 2030, USD Million
  • TABLE 45 Argentina Autism Spectrum Disorder Treatment Market, by Type, 2019 - 2022, USD Million
  • TABLE 46 Argentina Autism Spectrum Disorder Treatment Market, by Type, 2023 - 2030, USD Million
  • TABLE 47 Argentina Autism Spectrum Disorder Treatment Market, by Application, 2019 - 2022, USD Million
  • TABLE 48 Argentina Autism Spectrum Disorder Treatment Market, by Application, 2023 - 2030, USD Million
  • TABLE 49 Argentina Autism Spectrum Disorder Treatment Market, by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 50 Argentina Autism Spectrum Disorder Treatment Market, by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 51 UAE Autism Spectrum Disorder Treatment Market, 2019 - 2022, USD Million
  • TABLE 52 UAE Autism Spectrum Disorder Treatment Market, 2023 - 2030, USD Million
  • TABLE 53 UAE Autism Spectrum Disorder Treatment Market, by Type, 2019 - 2022, USD Million
  • TABLE 54 UAE Autism Spectrum Disorder Treatment Market, by Type, 2023 - 2030, USD Million
  • TABLE 55 UAE Autism Spectrum Disorder Treatment Market, by Application, 2019 - 2022, USD Million
  • TABLE 56 UAE Autism Spectrum Disorder Treatment Market, by Application, 2023 - 2030, USD Million
  • TABLE 57 UAE Autism Spectrum Disorder Treatment Market, by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 58 UAE Autism Spectrum Disorder Treatment Market, by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 59 Saudi Arabia Autism Spectrum Disorder Treatment Market, 2019 - 2022, USD Million
  • TABLE 60 Saudi Arabia Autism Spectrum Disorder Treatment Market, 2023 - 2030, USD Million
  • TABLE 61 Saudi Arabia Autism Spectrum Disorder Treatment Market, by Type, 2019 - 2022, USD Million
  • TABLE 62 Saudi Arabia Autism Spectrum Disorder Treatment Market, by Type, 2023 - 2030, USD Million
  • TABLE 63 Saudi Arabia Autism Spectrum Disorder Treatment Market, by Application, 2019 - 2022, USD Million
  • TABLE 64 Saudi Arabia Autism Spectrum Disorder Treatment Market, by Application, 2023 - 2030, USD Million
  • TABLE 65 Saudi Arabia Autism Spectrum Disorder Treatment Market, by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 66 Saudi Arabia Autism Spectrum Disorder Treatment Market, by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 67 South Africa Autism Spectrum Disorder Treatment Market, 2019 - 2022, USD Million
  • TABLE 68 South Africa Autism Spectrum Disorder Treatment Market, 2023 - 2030, USD Million
  • TABLE 69 South Africa Autism Spectrum Disorder Treatment Market, by Type, 2019 - 2022, USD Million
  • TABLE 70 South Africa Autism Spectrum Disorder Treatment Market, by Type, 2023 - 2030, USD Million
  • TABLE 71 South Africa Autism Spectrum Disorder Treatment Market, by Application, 2019 - 2022, USD Million
  • TABLE 72 South Africa Autism Spectrum Disorder Treatment Market, by Application, 2023 - 2030, USD Million
  • TABLE 73 South Africa Autism Spectrum Disorder Treatment Market, by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 74 South Africa Autism Spectrum Disorder Treatment Market, by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 75 Nigeria Autism Spectrum Disorder Treatment Market, 2019 - 2022, USD Million
  • TABLE 76 Nigeria Autism Spectrum Disorder Treatment Market, 2023 - 2030, USD Million
  • TABLE 77 Nigeria Autism Spectrum Disorder Treatment Market, by Type, 2019 - 2022, USD Million
  • TABLE 78 Nigeria Autism Spectrum Disorder Treatment Market, by Type, 2023 - 2030, USD Million
  • TABLE 79 Nigeria Autism Spectrum Disorder Treatment Market, by Application, 2019 - 2022, USD Million
  • TABLE 80 Nigeria Autism Spectrum Disorder Treatment Market, by Application, 2023 - 2030, USD Million
  • TABLE 81 Nigeria Autism Spectrum Disorder Treatment Market, by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 82 Nigeria Autism Spectrum Disorder Treatment Market, by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 83 Rest of LAMEA Autism Spectrum Disorder Treatment Market, 2019 - 2022, USD Million
  • TABLE 84 Rest of LAMEA Autism Spectrum Disorder Treatment Market, 2023 - 2030, USD Million
  • TABLE 85 Rest of LAMEA Autism Spectrum Disorder Treatment Market, by Type, 2019 - 2022, USD Million
  • TABLE 86 Rest of LAMEA Autism Spectrum Disorder Treatment Market, by Type, 2023 - 2030, USD Million
  • TABLE 87 Rest of LAMEA Autism Spectrum Disorder Treatment Market, by Application, 2019 - 2022, USD Million
  • TABLE 88 Rest of LAMEA Autism Spectrum Disorder Treatment Market, by Application, 2023 - 2030, USD Million
  • TABLE 89 Rest of LAMEA Autism Spectrum Disorder Treatment Market, by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 90 Rest of LAMEA Autism Spectrum Disorder Treatment Market, by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 91 Key Information - F. Hoffmann-La Roche Ltd.
  • TABLE 92 Key Information - Bristol Myers Squibb Company
  • TABLE 93 Key Information - Merck & Co., Inc.
  • TABLE 94 Key Information - Novartis AG
  • TABLE 95 Key Information - Eli Lilly And Company
  • TABLE 96 Key Information - Pfizer, Inc.
  • TABLE 97 Key Information - Johnson & Johnson
  • TABLE 98 key information - Otsuka Pharmaceutical Co., Ltd.
  • TABLE 99 Key Information - Yamo Pharmaceuticals
  • TABLE 100 Key Information - Curemark, LLC
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!